These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

297 related articles for article (PubMed ID: 1971185)

  • 1. Mycophenolic acid and thiazole adenine dinucleotide inhibition of Tritrichomonas foetus inosine 5'-monophosphate dehydrogenase: implications on enzyme mechanism.
    Hedstrom L; Wang CC
    Biochemistry; 1990 Jan; 29(4):849-54. PubMed ID: 1971185
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Species-specific inhibition of inosine 5'-monophosphate dehydrogenase by mycophenolic acid.
    Digits JA; Hedstrom L
    Biochemistry; 1999 Nov; 38(46):15388-97. PubMed ID: 10563825
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Crystal structure of a ternary complex of Tritrichomonas foetus inosine 5'-monophosphate dehydrogenase: NAD+ orients the active site loop for catalysis.
    Gan L; Petsko GA; Hedstrom L
    Biochemistry; 2002 Nov; 41(44):13309-17. PubMed ID: 12403633
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Action of the active metabolites of tiazofurin and ribavirin on purified IMP dehydrogenase.
    Yamada Y; Natsumeda Y; Weber G
    Biochemistry; 1988 Mar; 27(6):2193-6. PubMed ID: 2897864
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Kinetic mechanism of Tritrichomonas foetus inosine 5'-monophosphate dehydrogenase.
    Digits JA; Hedstrom L
    Biochemistry; 1999 Feb; 38(8):2295-306. PubMed ID: 10029522
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel mechanism of mycophenolic acid resistance in the protozoan parasite Tritrichomonas foetus.
    Hedstrom L; Cheung KS; Wang CC
    Biochem Pharmacol; 1990 Jan; 39(1):151-60. PubMed ID: 1967525
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Purification, characterization, and kinetic analysis of inosine 5'-monophosphate dehydrogenase of Tritrichomonas foetus.
    Verham R; Meek TD; Hedstrom L; Wang CC
    Mol Biochem Parasitol; 1987 May; 24(1):1-12. PubMed ID: 2886911
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Crystal structure of Tritrichomonas foetus inosine monophosphate dehydrogenase in complex with the inhibitor ribavirin monophosphate reveals a catalysis-dependent ion-binding site.
    Prosise GL; Wu JZ; Luecke H
    J Biol Chem; 2002 Dec; 277(52):50654-9. PubMed ID: 12235158
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dehydrogenase binding by tiazofurin anabolites.
    Goldstein BM; Bell JE; Marquez VE
    J Med Chem; 1990 Apr; 33(4):1123-7. PubMed ID: 1969483
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IMP dehydrogenase from the intracellular parasitic protozoan Eimeria tenella and its inhibition by mycophenolic acid.
    Hupe DJ; Azzolina BA; Behrens ND
    J Biol Chem; 1986 Jun; 261(18):8363-9. PubMed ID: 2873141
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Crystal structures of Tritrichomonasfoetus inosine monophosphate dehydrogenase in complex with substrate, cofactor and analogs: a structural basis for the random-in ordered-out kinetic mechanism.
    Prosise GL; Luecke H
    J Mol Biol; 2003 Feb; 326(2):517-27. PubMed ID: 12559919
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nucleoside and non-nucleoside IMP dehydrogenase inhibitors as antitumor and antiviral agents.
    Franchetti P; Grifantini M
    Curr Med Chem; 1999 Jul; 6(7):599-614. PubMed ID: 10390603
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Substitution of the conserved Arg-Tyr dyad selectively disrupts the hydrolysis phase of the IMP dehydrogenase reaction.
    Guillén Schlippe YV; Riera TV; Seyedsayamdost MR; Hedstrom L
    Biochemistry; 2004 Apr; 43(15):4511-21. PubMed ID: 15078097
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IMP dehydrogenase and action of antimetabolites in human cultured blast cells.
    Yamada Y; Goto H; Yoshino M; Ogasawara N
    Biochim Biophys Acta; 1990 Mar; 1051(3):209-14. PubMed ID: 1968764
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drug selectivity is determined by coupling across the NAD+ site of IMP dehydrogenase.
    Digits JA; Hedstrom L
    Biochemistry; 2000 Feb; 39(7):1771-7. PubMed ID: 10677226
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IMP dehydrogenase: inhibition by the anti-leukemic drug, tiazofurin.
    Yamada Y; Natsumeda Y; Yamaji Y; Jayaram HN; Tricot GJ; Hoffman R; Weber G
    Leuk Res; 1989; 13(2):179-84. PubMed ID: 2564451
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Kinetic mechanism of human inosine 5'-monophosphate dehydrogenase type II: random addition of substrates and ordered release of products.
    Wang W; Hedstrom L
    Biochemistry; 1997 Jul; 36(28):8479-83. PubMed ID: 9214292
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human IMP dehydrogenase catalyzes the dehalogenation of 2-fluoro- and 2-chloroinosine 5'-monophosphate in the absence of NAD.
    Antonino LC; Wu JC
    Biochemistry; 1994 Feb; 33(7):1753-9. PubMed ID: 7906542
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acid-base catalysis in the chemical mechanism of inosine monophosphate dehydrogenase.
    Markham GD; Bock CL; Schalk-Hihi C
    Biochemistry; 1999 Apr; 38(14):4433-40. PubMed ID: 10194364
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Crystal structure at 2.4 A resolution of Borrelia burgdorferi inosine 5'-monophosphate dehydrogenase: evidence of a substrate-induced hinged-lid motion by loop 6.
    McMillan FM; Cahoon M; White A; Hedstrom L; Petsko GA; Ringe D
    Biochemistry; 2000 Apr; 39(15):4533-42. PubMed ID: 10758003
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.